Vikas Khemani-backed Q-Line Biotech’s IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong subscription on its first day. Proceeds will be used for working capital, debt repayment, and general corporate purposes.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets